Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
Clinical trial NCT04343651 · COMPLETED
Trial details
- NCT number
- NCT04343651
- Sponsor
- CytoDyn, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2020-07-21
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.